Frontiers in Oncology | Cancer Molecular Targets and Therapeutics

Review

Published on 01 Apr 2025

Advancements in research on the precise eradication of cancer cells through nanophotocatalytic technology

in Cancer Molecular Targets and Therapeutics

Changyang Yao
Chensong Zhang
Dongwei Fan
Xuanhe Li
Shaofa Zhang
Daoxin Liu

Frontiers in Oncology

doi 10.3389/fonc.2025.1523444

1,172 views

Original Research

Published on 31 Mar 2025

Identification of MAD2L1 as a novel biomarker for hepatoblastoma through bioinformatics and machine learning approaches

in Cancer Molecular Targets and Therapeutics

Ying He
Xiwei Hao
Bin Hu
Nan Xia
Chaojin Wang
Xin Chen
Huanyu Zhang
Yuhe Duan
Qinglong Ying
Qian Dong

Frontiers in Oncology

doi 10.3389/fonc.2025.1524714

904 views

Review

Published on 31 Mar 2025

The role and regulatory mechanism of lysosome associated protein transmembrane 4β in tumors

in Cancer Molecular Targets and Therapeutics

Yuteng Yang
Yumei Li
Yaqi Wang
Xi Chen
Yisong Yao
Dongxian Li
Guohua Yu
Xicheng Song

Frontiers in Oncology

doi 10.3389/fonc.2025.1552007

1,028 views

Case Report

Published on 28 Mar 2025

Case Report: Personalized diagnosis and treatment strategies for three cases of cancer of unknown primary based on molecular testing techniques

in Cancer Molecular Targets and Therapeutics

Yao Ding
Kexue Zhou
Kaiwen Fu
Xingyun Liao
Shuanglong Xiong
Chengxiang Yang
Mingyang Hu
Guanzhong Liang
Xianghua Zeng
Yongsheng Li

Frontiers in Oncology

doi 10.3389/fonc.2025.1505271

1,024 views

Systematic Review

Published on 26 Mar 2025

Advances in bevacizumab in colorectal cancer: a bibliometric analysis from 2004 to 2023

in Cancer Molecular Targets and Therapeutics

Hao Chen
Yeqing Lei
Junjie Zhou
Chenhui Lv
Qijia Xuan

Frontiers in Oncology

doi 10.3389/fonc.2025.1552914

1,368 views

Original Research

Published on 24 Mar 2025

A seven-LncRNA signature for prognosis prediction of patients with lung squamous cell carcinoma through tumor immune escape

in Cancer Molecular Targets and Therapeutics

Qiangqiang Ge
Zhong Lin
Xuequan Wang
Zhengli Jiang
Yan Hu

Frontiers in Oncology

doi 10.3389/fonc.2025.1511564

985 views

Original Research

Published on 24 Mar 2025

Combination of MLo-1508 with sunitinib for the experimental treatment of papillary renal cell carcinoma

in Cancer Molecular Targets and Therapeutics

Ângela Marques-Magalhães
Filipa Moreira-Silva
Inês Graça
Paula C. Dias
Margareta P. Correia
Maria Ana Alzamora
Rui Henrique
Marie Lopez
Paola B. Arimondo
Vera Miranda-Gonçalves

Frontiers in Oncology

doi 10.3389/fonc.2025.1399956

1,319 views

Case Report

Published on 20 Mar 2025

Durable response to Olaparib in EGFR and somatic BRCA2-mutated lung adenocarcinoma with leptomeningeal metastases: a case report

in Cancer Molecular Targets and Therapeutics

Fang-fang Hou
Li-rong Liu
Wen-jie Zhao
Yan-chun Qu
Rui Zhou
Tian-lin Wang
Yong-song Ye
Xiao-shu Chai
Hai-bo Zhang

Frontiers in Oncology

doi 10.3389/fonc.2025.1512886

1,931 views
1 citation

Brief Research Report

Published on 18 Mar 2025

Spatial genomics reveals cholesterol metabolism as a key factor in colorectal cancer immunotherapy resistance

in Cancer Molecular Targets and Therapeutics

Andrew J. Kavran
Yulong Bai
Brian Rabe
Anna Kreshock
Andrew Fisher
Yelena Cheng
Anne Lewin
Chao Dai
Matthew J. Meyer
Konstantinos J. Mavrakis

Frontiers in Oncology

doi 10.3389/fonc.2025.1549237

1,505 views

Review

Published on 17 Mar 2025

Exploring therapeutic applications of PTEN, TMPRSS2:ERG fusion, and tumour molecular subtypes in prostate cancer management

in Cancer Molecular Targets and Therapeutics

Fidelis Charles Bugoye
Rispah Torrorey-Sawe
Richard Biegon
Nazima Dharsee
Fidelice Mafumiko
Herry Kibona
Said Aboud
Kirtika Patel
Simeon Mining

Frontiers in Oncology

doi 10.3389/fonc.2025.1521204

1,531 views

Original Research

Published on 14 Mar 2025

A novel lactylation-related gene signature to predict prognosis and treatment response in lung adenocarcinoma

in Cancer Molecular Targets and Therapeutics

Hongyi Zhang
Yihao Liu
Xuanguang Li
Chen Ding
Chunqiu Xia
Hua Huang
Hongyu Liu
Jun Chen

Frontiers in Oncology

doi 10.3389/fonc.2025.1549724

2,641 views

Brief Research Report

Published on 13 Mar 2025

Mapping MAGE-A4 expression in solid cancers for targeted therapies

in Cancer Molecular Targets and Therapeutics

Christin Habigt
Sylvie Rottey
Iben Spanggaard
Juanita S. Lopez
Elena Garralda
Emiliano Calvo
Oliver Bechter
Jayesh Desai
Rachel Galot
Leena Gandhi

Frontiers in Oncology

doi 10.3389/fonc.2025.1484182

1,628 views

Review

Published on 13 Mar 2025

Immuno-inflammatory mechanisms in cardio-oncology: new hopes for immunotargeted therapies

in Cancer Molecular Targets and Therapeutics

Meiqi Miao
Xinxin Liu
Han Zhang
Hailong Dai

Frontiers in Oncology

doi 10.3389/fonc.2025.1516977

1,615 views
1 citation

Review

Published on 11 Mar 2025

Therapies targeting triple-negative breast cancer: a perspective on anti-FGFR

in Cancer Molecular Targets and Therapeutics

Jinhao Chen
Qianru Wang
Hongyan Wu
Xiaofei Huang
Chunyu Cao

Frontiers in Oncology

doi 10.3389/fonc.2024.1415820

1,639 views

Original Research

Published on 07 Mar 2025

Prognostic value of CA125 in diffuse large B-cell lymphoma

in Cancer Molecular Targets and Therapeutics

Jie Zhang
Yijing Jiang
Long Chen
Linyan Xu
Bojian Ge
Xiaobing Miao
Xiaohong Xu

Frontiers in Oncology

doi 10.3389/fonc.2025.1548399

1,199 views

Editorial

Published on 05 Mar 2025

Editorial: Molecular mechanisms and therapeutic targets of cancer metastasis and therapy resistance

in Cancer Molecular Targets and Therapeutics

Ya-Wen Wang
Xu Chen

Frontiers in Oncology

doi 10.3389/fonc.2025.1571403

664 views